Antiseizure drug use in nursing homes before and after COVID-19
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how antiseizure medications are prescribed to long-term nursing home residents and how those prescriptions changed during the COVID-19 pandemic. It helps understand if prescribing patterns affected residents' health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in a nursing home for more than 100 days (long-stay resident).
- You must be 22 years or older.
- You must have continuous Medicare (fee-for-service or Advantage) and Part D drug coverage.
- You must stay in the nursing home for the full 3-month study period.
- You must be prescribed a psychoactive medication by a nursing home clinician.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to lower how often antibiotics are used in nursing home residents with Alzheimer’s disease and other dementias. It aims to make antibiotic use more appropriate while monitoring resident outcomes.
This trial tests a new approach to help manage behavioral and psychological symptoms of dementia (BPSD) for people living in long-term care facilities. It aims to improve care and quality of life for residents with dementia.
This study tests a better way for doctors to prescribe medicines for older nursing home residents. The goal is to make sure prescriptions are safer and more tailored to each person.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study tests whether bringing dental care to nursing home residents can reduce mouth infections, pneumonia, and help control blood sugar in people with diabetes. If you live in a nursing home and are 60 or older, you may be able to join.
This study tests a program to help doctors reduce the use of certain medications, like benzodiazepines, that may not be needed or could be harmful for older veterans in VA nursing homes (Community Living Centers). If you are a veteran 65 or older in a participating CLC and are not receiving hospice care, you may be eligible.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.